The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 16, 2026
Snapshot (as of Oct 16, 2026): Johnson & Johnson (JNJ) pays a $1.30 annual dividend ($0.33 quarterly), yielding 2.12% at $255.17/share. Next ex-dividend date 2026-11-24. 62+ consecutive years of dividend growth (Dividend King). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.12%
Annual Dividend: $1.30 per share
Payout Ratio: 60.7%
Ex-Dividend Date: 2026-11-24
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 65
Johnson & Johnson dividend income comes from one of the most established healthcare companies in the world, spanning drug development across oncology, immunology, and neuroscience, plus a MedTech segment covering orthopaedics, surgery, and vision. JNJ currently yields 1.99%, paying $5.28 per share annually in quarterly installments, with the next ex-dividend date on August 25, 2026. The last declared quarterly payment was $1.34 per share. With a beta of 0.235, this is a low-volatility Dividend King built for investors who prioritize payment reliability over yield size.
Johnson & Johnson pays out 60.0% of earnings as dividends, a payout ratio classified as elevated (60–75%). That level is supported by a business spanning two large segments: Innovative Medicine, which addresses high-demand therapeutic areas like oncology and cardiovascular disease, and MedTech, which serves recurring procedural needs in surgery and orthopaedics. Johnson & Johnson dividend safety holds up well at current payout levels, but a 60% ratio leaves less cushion than lower-payout peers, and any sustained earnings pressure from drug pricing or pipeline setbacks would narrow that buffer further.
Johnson & Johnson dividend history shows a CAGR of 6.1% per year from 2011 to 2025. The per-share annual dividend grew from $2.25 to $5.14 over that period (2026 data is partial and excluded from this calculation). The smallest annual increase in the window was 4.5% in 2024, which sets a realistic floor for what recent growth looks like.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +4.9% | $4.45 (2022) | $5.14 (2025) |
| 5-Year | +5.2% | $3.98 (2020) | $5.14 (2025) |
| 10-Year | +5.7% | $2.95 (2015) | $5.14 (2025) |
Johnson & Johnson fits dividend investors who want a long, unbroken payment record from a large healthcare business, and are willing to accept a low yield in exchange. The current yield of 1.99% is low (below 2%), though it sits above the 5-year average of 1.76%, meaning today's entry point offers slightly more income than the historical norm. Sixty-two consecutive years of dividend increases make JNJ a Dividend King with one of the longest increase streaks in the market. What an investor gets here is a 6.1% annual growth rate and extreme payment reliability. The trade-off is a yield that will not satisfy income-focused portfolios on its own.
JNJ is a Dividend King — 62 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-25 | $1.3400 |
| 2026-05-26 | $1.3400 |
| 2026-02-24 | $1.3000 |
| 2025-11-25 | $1.3000 |
| 2025-08-26 | $1.3000 |
| 2025-05-27 | $1.3000 |
| 2025-02-18 | $1.2400 |
| 2024-11-26 | $1.2400 |
| 2024-08-27 | $1.2400 |
| 2024-05-20 | $1.2400 |
| Year | Total Dividends |
|---|---|
| 2026 | $3.9800 |
| 2025 | $5.1400 |
| 2024 | $4.9100 |
| 2023 | $4.7000 |
| 2022 | $4.4500 |
Project income from JNJ with the JNJ dividend calculator or track your full portfolio with the dividend tracker.